Table 1.
(A)
|
(B)
|
||||||
---|---|---|---|---|---|---|---|
Incidence
|
Mortality
|
||||||
Males | Females | Males | Females | ||||
Lung and bronchus | 19.3% | Breast | 20.9% | Lung and bronchus | 30.5% | Lung and bronchus | 19.7% |
Colorectal | 15.0% | Colorectal | 13.2% | Colorectal | 15.0% | Colorectal | 14.2% |
Prostate | 11.0% | Lung and bronchus | 12.3% | Oral cavity and pharynx | 6.8% | Breast | 14.2% |
Oral cavity and pharynx | 7.5% | Corpus uteri | 4.0% | Prostate | 6.6% | Pancreas | 6.5% |
Bladder | 5.8% | Ovary | 3.6% | Stomach | 5.3% | Stomach | 4.9% |
Stomach | 3.8% | Pancreas | 3.6% | Pancreas | 5.0% | Ovary | 4.7% |
Kidney | 3.4% | Melanoma of skin | 3.2% | Bladder | 3.4% | Leukemia | 3.0% |
Pancreas | 3.3% | Cervix uteri | 3.1% | Liver | 2.8% | Gallbladder and biliary tract | 2.9% |
Larynx | 2.8% | Stomach | 3.0% | Esophagus | 2.7% | Cervix uteri | 2.8% |
Melanoma of skin | 2.7% | Bladder | 2.7% | Larynx | 2.6% | Brain | 2.0% |
Brain | 2.6% | Oral cavity and pharynx | 2.7% | Leukemia | 2.6% | Oral cavity and pharynx | 1.9% |
Leukemia | 2.5% | Kidney | 2.6% | Kidney | 2.4% | Kidney | 1.9% |
Liver | 2.5% | Non-Hodgkin lymphoma | 2.5% | Brain | 1.7% | Non-Hodgkin lymphoma | 1.9% |
Non-Hodgkin lymphoma | 2.2% | Brain | 2.5% | Non-Hodgkin lymphoma | 1.6% | Liver | 1.8% |
Esophagus | 1.9% | Leukemia | 2.4% | Gallbladder and biliary tract | 1.2% | Bladder | 1.8% |
Soft tissue | 1.8% | Soft tissue | 2.0% | Melanoma of skin | 1.1% | Corpus uteri | 1.8% |
Testis | 1.6% | Gallbladder and biliary tract | 1.9% | Multiple myeloma | 0.7% | Melanoma of skin | 1.0% |
Gallbladder and biliary tract | 1.2% | Liver | 1.8% | Testis | 0.3% | Multiple myeloma | 1.0% |
Bones and joints | 1.0% | Thyroid | 1.4% | Bones and joints | 0.1% | Esophagus | 0.7% |
Thyroid | 0.4% | Bones and joints | 0.9% | Hodgkin lymphoma | 0.1% | Larynx | 0.4% |
Other | 7.6% | Other | 9.5% | Other | 7.6% | Bones and joints | 0.1% |
All sites | 100% | All sites | 100% | All sites | 100% | Hodgkin lymphoma | 0.1% |
Other | 10.8% | ||||||
All sites | 100% |